Typhoid IgG/IgM Antibody Rapid Test
- UID
- MFG/IVD/2023/000113_f2f763222f8a2b1aa0036f9b23e18504_435014f9783b164a115771f335c8c59c
- Device class
- Class B
- Brand name
- Chimera
- License holder
- CHIMERA BIOTECH PRIVATE LIMITED
- Approving authority
- South Delhi Division
- Product information
- The Chimera® Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (Chimera) IgG and IgM in human serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi
Typhoid IgG/IgM Antibody Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000113_f2f763222f8a2b1aa0036f9b23e18504_435014f9783b164a115771f335c8c59c. This device is marketed under the brand name Chimera. The license holder is CHIMERA BIOTECH PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is South Delhi Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.